RegMed XB Explores Interest in Innovation Mission to Osaka, Japan
RegMed XB is exploring interest among startups, SMEs, and established companies to participate in a 5-day innovation mission to Osaka, Japan, planned for late January or early February 2027.
The mission is being organized in collaboration with Nakanoshima Qross (NQ), the International Hub for Future Medicine. Participants will gain first-hand insights into one of the world's most advanced regenerative medicine ecosystems and explore opportunities for collaboration, business development, and market entry in Japan and the wider Asian region.
What to expect
The program is currently being developed and is expected to include:
- Regulatory pathways and discussions with Japan's Pharmaceuticals and Medical Devices Agency (PMDA)
- Cell processing and manufacturing
- CMC and advanced therapy development
- Collaboration opportunities with Japanese and Asian stakeholders
- Business development and market entry support
- Visits to leading organizations within the regenerative medicine ecosystem
Why participate?
Japan has established itself as a global leader in regenerative medicine and advanced therapies, offering unique opportunities for innovation, partnerships, and commercialization.
This mission will provide participants with:
- Direct access to key stakeholders in Japan's regenerative medicine sector
- Insights into the Japanese regulatory and business environment
- Opportunities to explore strategic partnerships
- Exposure to market opportunities across Asia
Expression of interest
The number of places will be limited. RegMed XB therefore encourages interested organizations to express their interest at an early stage.Participation will be at the company's own expense.
Interested in joining?
Please contact Danielle Counotte at d.counotte@regmedxb.com and include the name of your organization.